Aberrant ALK and IGF-1R signaling have been demonstrated to contribute to oncogenic transformation in pediatric sarcomas [39] and the involvement of IGF-1R signaling in resistance to HDACi was reported in NSCLC [40]. This evidence concerns the gene ALK and non-small cell lung carcinoma.